Morgan Stanley’s Pacira BioSciences PCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$22.7M Sell
950,036
-47,570
-5% -$1.14M ﹤0.01% 2673
2025
Q1
$24.8M Sell
997,606
-107,168
-10% -$2.66M ﹤0.01% 2475
2024
Q4
$20.8M Sell
1,104,774
-491,115
-31% -$9.25M ﹤0.01% 2712
2024
Q3
$24M Buy
1,595,889
+1,079,724
+209% +$16.2M ﹤0.01% 2616
2024
Q2
$14.8M Sell
516,165
-154,162
-23% -$4.41M ﹤0.01% 2987
2024
Q1
$19.6M Sell
670,327
-700,341
-51% -$20.5M ﹤0.01% 2717
2023
Q4
$46.2M Buy
1,370,668
+909,345
+197% +$30.7M ﹤0.01% 2540
2023
Q3
$14.2M Sell
461,323
-98,033
-18% -$3.01M ﹤0.01% 2802
2023
Q2
$22.4M Buy
559,356
+28,025
+5% +$1.12M ﹤0.01% 2363
2023
Q1
$21.7M Buy
531,331
+91,961
+21% +$3.75M ﹤0.01% 2335
2022
Q4
$17M Buy
439,370
+37,582
+9% +$1.45M ﹤0.01% 2511
2022
Q3
$21.4M Sell
401,788
-26,742
-6% -$1.42M ﹤0.01% 2120
2022
Q2
$25M Buy
428,530
+146,456
+52% +$8.54M ﹤0.01% 2038
2022
Q1
$21.5M Buy
282,074
+43,922
+18% +$3.35M ﹤0.01% 2037
2021
Q4
$14.3M Sell
238,152
-13,533
-5% -$814K ﹤0.01% 2519
2021
Q3
$14.1M Sell
251,685
-171,819
-41% -$9.62M ﹤0.01% 2497
2021
Q2
$25.7M Buy
423,504
+141,309
+50% +$8.57M ﹤0.01% 1887
2021
Q1
$19.8M Buy
282,195
+51,345
+22% +$3.6M ﹤0.01% 1926
2020
Q4
$13.8M Buy
230,850
+34,783
+18% +$2.08M ﹤0.01% 2181
2020
Q3
$11.8M Buy
196,067
+66,640
+51% +$4.01M ﹤0.01% 1896
2020
Q2
$6.79M Sell
129,427
-23,752
-16% -$1.25M ﹤0.01% 2346
2020
Q1
$5.14M Sell
153,179
-93,863
-38% -$3.15M ﹤0.01% 2438
2019
Q4
$11.2M Buy
247,042
+76,745
+45% +$3.48M ﹤0.01% 2311
2019
Q3
$6.48M Buy
170,297
+143,633
+539% +$5.47M ﹤0.01% 2597
2019
Q2
$1.16M Sell
26,664
-2,055
-7% -$89.3K ﹤0.01% 4146
2019
Q1
$1.09M Sell
28,719
-230,751
-89% -$8.78M ﹤0.01% 4045
2018
Q4
$11.2M Sell
259,470
-16,299
-6% -$701K ﹤0.01% 2015
2018
Q3
$13.6M Buy
275,769
+166,933
+153% +$8.2M ﹤0.01% 2092
2018
Q2
$3.49M Sell
108,836
-23,112
-18% -$741K ﹤0.01% 3566
2018
Q1
$4.11M Buy
131,948
+10,525
+9% +$328K ﹤0.01% 3236
2017
Q4
$5.54M Buy
121,423
+27,389
+29% +$1.25M ﹤0.01% 3011
2017
Q3
$3.53M Sell
94,034
-85,106
-48% -$3.2M ﹤0.01% 3328
2017
Q2
$8.55M Buy
179,140
+90,988
+103% +$4.34M ﹤0.01% 2323
2017
Q1
$4.02M Sell
88,152
-32,416
-27% -$1.48M ﹤0.01% 3092
2016
Q4
$3.89M Buy
120,568
+10,221
+9% +$330K ﹤0.01% 3260
2016
Q3
$3.78M Sell
110,347
-245,919
-69% -$8.42M ﹤0.01% 2947
2016
Q2
$12M Buy
356,266
+296,240
+494% +$9.99M ﹤0.01% 1827
2016
Q1
$3.18M Sell
60,026
-60,588
-50% -$3.21M ﹤0.01% 2933
2015
Q4
$9.26M Buy
120,614
+26,865
+29% +$2.06M ﹤0.01% 2056
2015
Q3
$3.85M Buy
93,749
+29,166
+45% +$1.2M ﹤0.01% 2888
2015
Q2
$4.57M Sell
64,583
-11,827
-15% -$836K ﹤0.01% 2868
2015
Q1
$6.79M Sell
76,410
-77,586
-50% -$6.89M ﹤0.01% 2454
2014
Q4
$13.7M Buy
153,996
+55,035
+56% +$4.88M 0.01% 1778
2014
Q3
$9.59M Buy
98,961
+55,349
+127% +$5.36M ﹤0.01% 2057
2014
Q2
$4.01M Sell
43,612
-61,259
-58% -$5.63M ﹤0.01% 2872
2014
Q1
$7.34M Buy
104,871
+76,553
+270% +$5.36M ﹤0.01% 2215
2013
Q4
$1.63M Sell
28,318
-7,851
-22% -$451K ﹤0.01% 3533
2013
Q3
$1.74M Buy
36,169
+8,084
+29% +$389K ﹤0.01% 3343
2013
Q2
$814K Buy
+28,085
New +$814K ﹤0.01% 3885